(Q39182781)

9 September 2017

title

Dopaminergic potency of apomorphine homologues in mice with unilateral lesions of the caudate nucleus (English)

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

25 March 2022

1 reference

1 reference

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

25 March 2022

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

25 March 2022

author name string

J. Pearl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A24097

25 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=24097

25 March 2022

publication date

1 February 1978

1 reference

full work available at URL

9 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.2042-7158.1978.tb13176.x

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

http://academic.oup.com/jpp/article-pdf/30/1/118/37759066/j.2042-7158.1978.tb13176.x.pdf

25 March 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

Journal of Pharmacy and Pharmacology

25 March 2022

published in

1 reference

9 September 2017

volume

30

1 reference

9 September 2017

issue

2

1 reference

9 September 2017

page(s)

118-119

1 reference

Emetic activity of N-substituted norapomorphines

9 September 2017

cites work

0 references

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

3

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas

23 October 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

Treatment of Parkinson's disease with aporphines. Possible role of growth hormone

23 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines

23 October 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

Centrally acting emetics. II. Norapomorphine and derivatives

23 October 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

Rotatory behavior induced in nigra-lesioned rats by n-propylnoraporphine, apomorphine, and levodopa

23 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain

23 October 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

Aporphines. 21. Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines

23 October 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

Comparison of structural and stereoisomers of apomorphine on stereotyped behavior of the rat

23 October 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1978.TB13176.X

23 October 2022

Identifiers

0 references

1 reference